Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010162 | 0.95 | GSR (0.43) | OR51E2CPB2GSRRNPEP | |
| SCHEMBL6010251 | 0.80 | GSR (0.42) | OR51E2CPB2GSRRNPEP | |
| SCHEMBL6010143 | 0.79 | OR51E2 (0.50) | OR51E2GABRR1 | |
| SCHEMBL9716741 | 0.79 | GABRR1 (0.41) | CPB2GSRRNPEPGABRR1 | |
| SCHEMBL9716745 | 0.79 | GABRR1 (0.41) | CPB2GSRRNPEPGABRR1 | |
| SCHEMBL6009469 | 0.79 | TET2 (0.47) | OR51E2GSR | |
| SCHEMBL6010425 | 0.77 | OR51E2 (0.32) | OR51E2 | |
| SCHEMBL7265699 | 0.76 | GSR (0.44) | CPB2GSRRNPEPGABRR1 | |
| SCHEMBL7265705 | 0.76 | GSR (0.44) | CPB2GSRRNPEPGABRR1 | |
| SCHEMBL21855292 | 0.75 | GSR (0.38) | OR51E2CPB2GSRRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | OR51E2 2335/4885CPB2 3245/4885GSR 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.